drugset / Trial / NCT03239535
Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy
Phase 1/2
Unknown
40 enrolled
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Non-randomizedParallel-groupSingle-blindTreatment
Summary
The clinical trial aims to study the safety and efficacy of adult allogeneic mesenchymal stem cells for the treatment of critical limb ischemia.
Timeline
- Start
- 2013-10-01
- Primary completion
- 2018-08-01
- Completion
- 2018-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | — | Intramuscular |